Investors in Science

Segulah Medical Acceleration specializes in investing in and nurturing transformative businesses focused on medical technologies and associated value chain solutions. These companies leverage cutting-edge research to develop real-world applications in areas like medical devices, diagnostics, and life science tools. Segulah Medical Acceleration plays a pivotal role in bridging the gap between innovative concepts and commercial validation, facilitating the global market entry of advanced medical research solutions.

Almi Invest is renowned as Sweden's leading investor in startups, operating through eight regional VC funds and one national Green Tech fund across the country. Managing a substantial equity pool of SEK 3.5 billion, Almi Invest has backed approximately 660 startups since its inception. The company's successful investments have resulted in acquisitions by major industry giants like Google, Apple, Microsoft, and Qlik, as well as through IPOs. Almi Invest operates as a venture capital firm within the Almi Group, supported by the European Regional Development Fund, Almi, Almi Invest, and regional stakeholders.

Granitor specializes in investing in cutting-edge technologies with significant commercial potential and global relevance. Primarily focused on Swedish companies, Granitor supports innovations in solar-powered water purification, sustainable food production, environmentally neutral energy solutions, zero-emissions transportation, and breakthrough medicines for previously untreatable diseases. By making early investments and maintaining a long-term commitment, Granitor aims to propel sustainable innovations forward, bridging the gap to market adoption. The firm's philosophy emphasizes active engagement and strategic leadership, playing a pivotal role in the operational and strategic development of its portfolio companies.

Navigare Ventures is an early-stage investor specializing in science-driven companies, focusing on deep tech sectors such as advanced computing, quantum technologies, synthetic biology, advanced materials, and data-driven life sciences. They are committed long-term investors, supporting companies from Seed to Series A and beyond, and emphasize forming enduring partnerships with founders. Navigare Ventures leverages their extensive industrial and scientific networks to provide capital, networks, and expertise to facilitate the transformation of science startups into successful enterprises.

HealthCap is a European venture capital firm investing globally in life sciences and has raised eight funds since 1996. HealthCap has backed and built more than 127 companies, taken more than 45 companies public, and completed numerous trade sales. The investment strategy focuses on diseases with a high unmet medical need and breakthrough therapies that have the potential to be transformative, change clinical practice, and change the lives of patients suffering from these conditions.

Trill Impact operates as a dedicated Impact House focused exclusively on impact investments. Their unique design ensures that all investments are aimed at generating positive returns while making significant impacts on people, the planet, and investors alike.

Curitas Ventures is a Stockholm based VC, launched by Mikael Ahlström and Gerda Larsson in 2020. We invest in teams determined to build something out of the ordinary within the field of Disruptive Tech and Life Science.

Bonit Capital, a Swedish family-owned investment company, engages in diverse sectors and asset classes, including social investments and outcome models. In Venture Capital, Bonit focuses on life sciences, providing capital and industry expertise to ambitious founders in digital health, medical technology, and diagnostics.

Crosslight Partners tackles substantial challenges within the food system with innovative solutions. These companies are at the early growth stage, demonstrating commercial traction. Investments typically range from SEK 1 to 10 million, with flexible ownership stakes. While the focus is global, emphasis lies on the Nordics and Europe. The investment horizon spans 3 to 7 years, and governance involvement includes securing a board seat or holding quarterly follow-up meetings.

The Nordic region is at the forefront of the technology and scientific revolution. Northislet's vision is to help create and build Nordic champions within Life Science, allowing them to grow and reach their potential in the hands of local entrepreneurs, employees, and shareholders. Their goal is to create long-term value for all stakeholders, fostering a prosperous environment for new and existing companies, entrepreneurs, and scientists, making the Nordic region a competitive and attractive place for global talent within Life Science. Northislet aims to become a leading Nordic investment company in Life Science over the next 25 years, with the journey just beginning.

Ysios Capital, a leading Spanish venture capital firm, provides private equity financing to early and mid-stage life science companies that develop disruptive therapeutic products and platform technologies. Founded in 2008, Ysios Capital manages over USD 420M through three dedicated funds in life sciences and is led by a team of professionals experienced in building biotech companies.

Copernion Group operates as a tech corporation dedicated to fostering, investing in, and advising tech startups, leveraging a Corporate Venture structure to offer opportunities for third-party involvement and achieve significant returns. Central to its strategy is the Copernion Circle, an active platform comprising over 350 influential members globally. These professionals, ranging from presidents to CEOs, contribute to Copernion Group's growth and impact across 19 countries, supporting its diverse portfolio of 26 companies. Notably, Copernion Group has catalyzed Spain's sole deep-tech unicorn, delivering substantial returns and generating over 2,400 jobs for young professionals. With operations spanning across Europe, the Americas, and beyond, Copernion Group applies an innovative investment model across various tech sectors, backed by extensive expertise in cutting-edge technologies like AI, Big Data, and Robotics. Their commitment to sustainable investment underscores their focus on creating high societal impact alongside financial success.